Enzo Biochem said last week that its subsidiary, Enzo Life Sciences, has launched a new amplification method for improving gene-expression data from microarray experiments.
According to the company, the method is able to amplify either the antisense or sense strand of RNA, and will be marketed in various formats.
The first product amplifies the antisense strand of RNA.
Ambion has recently introduced Anti-miR microRNA inhibitors.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
